Effects of Raltegravir Based Regimen on Platelet Reactivity, Platelet-monocyte Aggregation and Immune Activation

NCT02383355 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

DRUG: Raltegravir
DRUG: Continuation of own regimen

Sponsor

Radboud University Medical Center

Collaborators

[object Object]